We are live on
!
Find out more
PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Est. Return
55.92%
This Fund
S&P 500
This Quarter
Est. Return
+10.2%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$59.7M
AUM Growth
-$6.32M
(-9.6%)
Cap. Flow
-$7.91M
Cap. Flow
% of AUM
-13.25%
Top 10 Holdings %
Top 10 Hldgs %
41.08%
Holding
87
New
22
Increased
18
Reduced
19
Closed
22
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.7M |
| 2 |
Amazon
AMZN
|
+$1.55M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1.47M |
| 4 |
Alibaba
BABA
|
+$1.38M |
| 5 |
Synchrony
SYF
|
+$1.03M |
Top Sells
| 1 |
Pfizer
PFE
|
+$2.87M |
| 2 |
UnitedHealth
UNH
|
+$2.81M |
| 3 |
HCA Healthcare
HCA
|
+$2.53M |
| 4 |
Gilead Sciences
GILD
|
+$2.26M |
| 5 |
Eli Lilly
LLY
|
+$1.84M |
Sector Composition
| 1 | Healthcare | 52.15% |
| 2 | Technology | 8.57% |
| 3 | Industrials | 7.58% |
| 4 | Financials | 7.48% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
| $3.96M | 6.64% |
46,558
+4,765
| +11% | +$405K |
|
2
Bristol-Myers Squibb
BMY
$116B
| $3.37M | 5.64% |
48,922
+14,279
| +41% | +$944K |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $3.05M | 5.12% |
9,769
-2,016
| -17% | -$600K |
|
4
Teva Pharmaceuticals
TEVA
$37.1B
| $2.49M | 4.18% |
37,993
+7,801
| +26% | +$482K |
|
5
Palo Alto Networks
PANW
$288B
| $2.42M | 4.05% |
82,314
+28,854
| +54% | +$833K |
|
6
AerCap
AER
$23.1B
| $2.11M | 3.53% |
48,829
+14,266
| +41% | +$597K |
|
7
Edwards Lifesciences
EW
$51.9B
| $1.86M | 3.11% |
70,482
-20,730
| -23% | -$538K |
|
|
MDCO
8
DELISTED
Medicines Co
MDCO
| $1.81M | 3.03% |
48,493
+12,094
| +33% | +$457K |
|
|
9
Alphabet (Google) Class A
GOOGL
$4.39T
| $1.79M | 3% |
+45,960
| New | +$1.7M |
|
|
10
Amazon
AMZN
$2.66T
| $1.66M | 2.78% |
+49,140
| New | +$1.55M |
|
11
Vulcan Materials
VMC
$37.9B
| $1.62M | 2.72% |
17,096
+1,752
| +11% | +$170K |
|
12
Jazz Pharmaceuticals
JAZZ
$15B
| $1.55M | 2.6% |
11,044
+2,908
| +36% | +$403K |
|
|
SCHW
13
Charles Schwab
SCHW
$176B
| $1.53M | 2.56% |
+46,441
| New | +$1.47M |
|
|
14
Alibaba
BABA
$269B
| $1.43M | 2.4% |
+17,610
| New | +$1.38M |
|
15
Universal Health Services
UHS
$8.73B
| $1.39M | 2.33% |
11,628
+635
| +6% | +$77.6K |
|
16
Heron Therapeutics
HRTX
$81.4M
| $1.25M | 2.1% |
46,938
-5,009
| -10% | -$134K |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | 2.07% |
35,300
-11,979
| -25% | -$773K |
|
|
ALDR
18
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.21M | 2.03% |
36,756
+13,831
| +60% | +$468K |
|
|
AERI
19
DELISTED
Aerie Pharmaceuticals
AERI
| $1.21M | 2.02% |
49,556
-170
| -0.3% | -$3.97K |
|
|
AET
20
DELISTED
Aetna Inc
AET
| $1.2M | 2.01% |
11,075
-2,815
| -20% | -$304K |
|
|
ACOR
21
DELISTED
Acorda Therapeutics
ACOR
| $1.2M | 2% |
233
+49
| +27% | +$214K |
|
22
Textron
TXT
$15.6B
| $1.1M | 1.85% |
26,272
+20,373
| +345% | +$842K |
|
23
Lam Research
LRCX
$433B
| $1.07M | 1.79% |
+134,420
| New | +$1.01M |
|
|
24
Synchrony
SYF
$24.8B
| $1M | 1.68% |
+32,910
| New | +$1.03M |
|
|
HOLX
25
DELISTED
Hologic
HOLX
| $986K | 1.65% |
25,488
+578
| +2% | +$22.5K |
|
Similar funds
SWM
EAM
BO
ACM
SL
DII
FIM
EM